Structural definition for a new modality of broad and potent antibody neutralization at the CD4-binding site on HIV-1 gp120

Structural definition for a new modality of broad and potent antibody neutralization at the CD4-binding site on HIV-1 gp120

Bibliographic Details
Main Authors:	Zhou T, Moquin S, Lynch R, Wu X, Zhu J, Yang Y, Zhang B, Mascola JR, Kwong PD
Format:	Article
Language:	English
Published:	BMC 2012-09-01
Series:	Retrovirology

Similar Items

Bispecific Anti-HIV Immunoadhesins That Bind Gp120 and Gp41 Have Broad and Potent HIV-Neutralizing Activity
by: Seth H. Pincus, et al.
Published: (2021-07-01)

Characteristics of HIV-1 gp120 molecules that bind ancestor, intermediate and mature forms of VRC01-like antibodies
by: Joyce M, et al.
Published: (2012-09-01)

Glycan modifications to the gp120 immunogens used in the RV144 vaccine trial improve binding to broadly neutralizing antibodies.
by: Rachel C Doran, et al.
Published: (2018-01-01)

Hyperglycosylated resurfaced stabilized GP120 core as an immunogen elicits antibodies targeted at the CD4-binding site
by: Dai K, et al.
Published: (2012-09-01)

454 pyrosequencing and bioinformatics analysis of the lineage of the broad and potent gp41-directed antibody 10e8
by: Ofek G, et al.
Published: (2012-09-01)

Super Potent Bispecific Llama VHH Antibodies Neutralize HIV via a Combination of gp41 and gp120 Epitopes
by: Nika M. Strokappe, et al.
Published: (2019-06-01)

Development of a Stable MGAT1− CHO Cell Line to Produce Clade C gp120 With Improved Binding to Broadly Neutralizing Antibodies
by: Rachel C. Doran, et al.
Published: (2018-10-01)

A human antibody to the CD4 binding site of gp120 capable of highly potent but sporadic cross clade neutralization of primary HIV-1.
by: Johannes S Gach, et al.
Published: (2013-01-01)

Straightforward selection of broadly neutralizing single-domain antibodies targeting the conserved CD4 and co-receptor binding sites of HIV-1 gp120
by: Matz J, et al.
Published: (2012-09-01)

Identification and characterization of a broadly cross-reactive HIV-1 human monoclonal antibody that binds to both gp120 and gp41.
by: Mei-Yun Zhang, et al.
Published: (2012-01-01)

The mapping and characterization of a novel binding site on HIV-1 gp120 for the broadly neutralizing monoclonal antibody IgG1 b12
by: Waruk, Jillian
Published: (2011)

The mapping and characterization of a novel binding site on HIV-1 gp120 for the broadly neutralizing monoclonal antibody IgG1 b12
by: Waruk, Jillian
Published: (2011)

Unusual Cysteine Content in V1 Region of gp120 From an Elite Suppressor That Produces Broadly Neutralizing Antibodies
by: Jennie M. Hutchinson, et al.
Published: (2019-05-01)

P04-38. Crystal structure of gp120 in complex with the CD4-binding-site antibody b13 suggests precise targeting is needed for neutralization
by: Kwong PD, et al.
Published: (2009-10-01)

Structural definition of a novel CD4-induced epitope that is targeted by a single-headed immunoglobulin to effect broad and potent HIV neutralization
by: Acharya P, et al.
Published: (2012-09-01)

Geospatial HIV-1 subtype C gp120 sequence diversity and its predicted impact on broadly neutralizing antibody sensitivity.
by: Jyoti Sutar, et al.
Published: (2021-01-01)

Broadly neutralizing antibody PGT121 allosterically modulates CD4 binding via recognition of the HIV-1 gp120 V3 base and multiple surrounding glycans.
by: Jean-Philippe Julien, et al.
Published: (2013-01-01)

CD169-mediated trafficking of HIV to plasma membrane invaginations in dendritic cells attenuates efficacy of anti-gp120 broadly neutralizing antibodies.
by: Hisashi Akiyama, et al.
Published: (2015-03-01)

A short segment in the HIV-1 gp120 V1/V2 region is a major determinant of neutralization resistance to PG9-like antibodies
by: Doria-Rose NA, et al.
Published: (2012-09-01)

Antibodies to the CD4-binding site of HIV-1 gp120 suppress gp120-specific CD4 T cell response while enhancing antibody response
by: Hioe Catarina E, et al.
Published: (2008-07-01)

Correction: CD169-Mediated Trafficking of HIV to Plasma Membrane Invaginations in Dendritic Cells Attenuates Efficacy of Anti-gp120 Broadly Neutralizing Antibodies.
by: PLOS Pathogens Staff
Published: (2015-05-01)

Fusion Complexes and CD4-independent gp120s for the Induction of HIV-1 Neutralizing Antibodies
by: Lopalco L, et al.
Published: (2005-12-01)

Engineering of HIV gp120 by yeast surface display for neutralizing antibody characterization and immunogen design
by: Mata-Fink, Jordi
Published: (2013)

Structural basis for germline gene usage of a potent class of antibodies targeting the CD4 binding site of HIV-1 gp120
by: West AP, et al.
Published: (2012-09-01)

Eliciting broadly neutralizing antibodies against HIV-1 that target gp41 MPER
by: Han D, et al.
Published: (2012-09-01)

HIV-1 envelope gp41 broadly neutralizing antibodies: hurdles for vaccine development.
by: Laurent Verkoczy, et al.
Published: (2014-05-01)

NMR spectroscopy of HIV-1 gp120 outer domain
by: Sastry M, et al.
Published: (2012-09-01)

Neutralization diversity of HIV-1 Indian subtype C envelopes obtained from cross sectional and followed up individuals against broadly neutralizing monoclonal antibodies having distinct gp120 specificities
by: Ranajoy Mullick, et al.
Published: (2021-05-01)

Novel vomputational methods for predicting epitopes of potent and broadly neutralizing HIV-1 antibodies
by: Evans MC, et al.
Published: (2012-09-01)

Recognition and penetration of the HIV-1 Env glycan shield by potent broadly neutralizing antibodies
by: Julien J, et al.
Published: (2012-09-01)

Prime-boost immunization of rabbits with HIV-1 gp120 elicits potent neutralization activity against a primary viral isolate.
by: Kristin M Narayan, et al.
Published: (2013-01-01)

Select gp120 V2 domain specific antibodies derived from HIV and SIV infection and vaccination inhibit gp120 binding to α4β7.
by: Sakaorat Lertjuthaporn, et al.
Published: (2018-08-01)

Rapid development of cross-clade neutralizing antibody responses after clade B gp120/gp140 protein priming and clade c gp140 protein boosting
by: Spearman P, et al.
Published: (2012-09-01)

Investigation of a Putative Secondary Binding Site between the Broadly Neutralizing Monoclonal anti-HIV-1 Antibody and its Antigen gp41
by: Wierzbicka, Marta
Published: (2010)

Investigation of a Putative Secondary Binding Site between the Broadly Neutralizing Monoclonal anti-HIV-1 Antibody and its Antigen gp41
by: Wierzbicka, Marta
Published: (2010)

Characterization of RNA aptamers that bind to HIV-1 gp120
by: Cohen, Carla J.
Published: (2006)

Allosteric modulation of the HIV-1 gp120-gp41 association site by adjacent gp120 variable region 1 (V1) N-glycans linked to neutralization sensitivity.
by: Heidi E Drummer, et al.
Published: (2013-01-01)

Broad and potently neutralizing monoclonal antibodies isolated from human survivors of New World hantavirus infection
by: Taylor B. Engdahl, et al.
Published: (2021-05-01)

Role of anti-CD4-binding site antibodies in modulating gp120-specific CD4 T cell and antibody responses
by: Gorny MK, et al.
Published: (2006-12-01)

Synergistic Effect by Combining a gp120-Binding Protein and a gp41-Binding Antibody to Inactivate HIV-1 Virions and Inhibit HIV-1 Infection
by: Xinling Wang, et al.
Published: (2021-03-01)